These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26751558)

  • 1. Regulation of drug-metabolizing enzymes by local and systemic liver injuries.
    Guo Y; Hu B; Xie Y; Billiar TR; Sperry JL; Huang M; Xie W
    Expert Opin Drug Metab Toxicol; 2016; 12(3):245-51. PubMed ID: 26751558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition.
    Shi S; Li Y
    Curr Drug Metab; 2014; 15(10):915-41. PubMed ID: 25828591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species.
    van Groen BD; Nicolaï J; Kuik AC; Van Cruchten S; van Peer E; Smits A; Schmidt S; de Wildt SN; Allegaert K; De Schaepdrijver L; Annaert P; Badée J
    Pharmacol Rev; 2021 Apr; 73(2):597-678. PubMed ID: 33608409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of liver diseases on drug-metabolizing enzymes: implications for drug fate alterations and nano-therapeutic openings.
    Lu L; Shi J; Li Q; Peng X; Dong L; Li Y; Dai P; Wang Y; Guo E; Zhou F; Liu Z
    Curr Med Chem; 2014; 21(22):2522-41. PubMed ID: 24358976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug disposition in pathophysiological conditions.
    Gandhi A; Moorthy B; Ghose R
    Curr Drug Metab; 2012 Nov; 13(9):1327-44. PubMed ID: 22746301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: a review.
    Korashy HM; Elbekai RH; El-Kadi AO
    Xenobiotica; 2004 Jan; 34(1):1-29. PubMed ID: 14742134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Liver Disease on Hepatic Transporter Expression and Function.
    Thakkar N; Slizgi JR; Brouwer KLR
    J Pharm Sci; 2017 Sep; 106(9):2282-2294. PubMed ID: 28465155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology.
    Nigam SK; Bush KT; Bhatnagar V; Poloyac SM; Momper JD
    Clin Pharmacol Ther; 2020 Jul; 108(1):40-53. PubMed ID: 32119114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and Regulation of Drug Transporters and Metabolizing Enzymes in the Human Gastrointestinal Tract.
    Drozdzik M; Oswald S
    Curr Med Chem; 2016; 23(39):4468-4489. PubMed ID: 27781942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis.
    Canet MJ; Cherrington NJ
    Expert Opin Drug Metab Toxicol; 2014 Sep; 10(9):1209-19. PubMed ID: 24989624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of drug metabolizing enzymes and transporters in the cochlea: Implications for drug delivery and ototoxicity.
    Kennon-McGill S; Clemens MM; McGill MR
    Hear Res; 2019 Aug; 379():98-102. PubMed ID: 31121337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of drug-metabolizing enzymes in infectious and inflammatory disease: implications for biologics-small molecule drug interactions.
    Mallick P; Taneja G; Moorthy B; Ghose R
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):605-616. PubMed ID: 28537216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders.
    Wu KC; Lin CJ
    J Food Drug Anal; 2019 Jan; 27(1):48-59. PubMed ID: 30648594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication.
    Momper JD; Nigam SK
    Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):561-570. PubMed ID: 29746174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of brain drug metabolizing enzymes and transporters by nuclear receptors.
    Xu D; Huang S; Wang H; Xie W
    Drug Metab Rev; 2018 Nov; 50(4):407-414. PubMed ID: 30501435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
    Mao Q; Lai Y; Wang J
    Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INTEDE: interactome of drug-metabolizing enzymes.
    Yin J; Li F; Zhou Y; Mou M; Lu Y; Chen K; Xue J; Luo Y; Fu J; He X; Gao J; Zeng S; Yu L; Zhu F
    Nucleic Acids Res; 2021 Jan; 49(D1):D1233-D1243. PubMed ID: 33045737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Disease Pathologies on Transporter Expression and Function.
    Atilano-Roque A; Roda G; Fogueri U; Kiser JJ; Joy MS
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S205-21. PubMed ID: 27385176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transporters in hepatic drug disposition: an update.
    Li P; Wang GJ; Robertson TA; Roberts MS
    Curr Drug Metab; 2009 Jun; 10(5):482-98. PubMed ID: 19689245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microRNAs in the regulation of drug metabolism and disposition.
    Yu AM
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1513-28. PubMed ID: 19785514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.